Gene Therapies (ELRIG)

Speaker - Funded(s)

• 

  Pinar Akcakaya, PhD (she/her/hers)

  Director, Therapeutic Editing
  AstraZeneca, Sweden
• 

  Anura Rambukkana, PhD (he/him/his)

  Professor
  University of Edinburgh, United Kingdom

Speaker - Not Funded(s)

• 

  David McClymont, PhD

  Head of Automation
  Horizon Discovery Ltd, United Kingdom

Presentations:

• 14:30 – 15:00 CET

  Development of Innovative Regenerative Therapeutic Strategies by Translating Bacterial Ingenuity of Reprogramming and Organ Growth
  

  Anura Rambukkana, PhD (he/him/his) – University of Edinburgh
• 15:00 – 15:30 CET

  Novel technologies for development of safer therapeutic genome editing medicines
  

  Pinar Akcakaya, PhD (she/her/hers) – AstraZeneca
• 15:30 – 16:00 CET

  Meeting the gene editing potential of cell line engineering with image analysis, abstraction and automation
  

  David McClymont, PhD – Horizon Discovery Ltd